Technical Articles
thalidomide
Why Biotinylated CRBN/DDB1 Became a Tool Position on Degradation-Drug Platforms
Molecular-glue and PROTAC platforms converge on CRBN-DDB1 engagement assays. This article traces the translational narrative behind the standardized tool.
View details
- Drug Research
- biotinylated CRBN DDB1
- molecular glue
- PROTAC
- protein degradation
- thalidomide
- standardization
- UA080262
CRBN-DDB1 and Molecular Glues: From the Thalidomide Controversy to the New Paradigm of Targeted Degradation
A once-withdrawn old drug revealed, sixty years later, an entirely new paradigm of targeted protein degradation. This article follows the timeline of how CRBN-DDB1 moved from the thalidomide mystery to center stage of molecular glue therapeutics.
View details
- Drug Research
- CRBN-DDB1
- Molecular glue
- Thalidomide
- Lenalidomide
- Targeted protein degradation
- UA085062
- 1







